Report cover image

Blood Testing Market Share, Size, Trends, Industry Analysis Report, By Test (CBC test, Blood glucose test, Lipid panel testing, Covid-19, BUN testing (Blood Urea Nitrogen), A1C, Cortisol, Creatinine, Others), By Product, By Method, By End-Use, By Region,

Published Sep 01, 2025
Length 118 Pages
SKU # PLRS20470445

Description

The blood testing market size is expected to reach USD 233.74 Billion by 2034, according to a new study by Polaris Market Research. The report “Blood Testing Market Share, Size, Trends, Industry Analysis Report, By Test (CBC test, Blood glucose test, Lipid panel testing, Covid-19, BUN testing (Blood Urea Nitrogen), A1C, Cortisol, Creatinine, Others), By Product, By Method, By End-Use, By Region, Segments & Forecast, 2025 – 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of chronic and infectious diseases, technological advancements in blood testing devices, and the need for point-of-care (POC) testing centers are the prime factors expected to drive the market in the forecast period.

A blood test is a medical procedure in which a healthcare professional draws blood samples from a patient's vein using a needle, syringe, or another device. Blood tests are used for various purposes, including diagnosing diseases and medical conditions, monitoring the effectiveness of treatments, and evaluating overall health.

The increasing prevalence of chronic and infectious diseases drives demand for blood testing services and products, creating growth opportunities for companies in the blood testing market. Companies that can provide innovative, accurate, and cost-effective solutions to meet the growing demand for blood testing are likely to succeed in this dynamic market.

For instance, as per International Diabetes Federation, India has the highest number of people with diabetes in the world with about 77 million people living with diabetes and was projected to reach a value of 134 million by 2045. The increasing chronic diseases in India and other countries have necessitated blood testing to detect the disease.

Blood glucose test is expected to account for the fastest growth rate in the forecast period. The growth of the blood glucose test segment is driven by the rising prevalence of diabetes, technological advancements, increasing awareness of the importance of monitoring blood glucose, and various government initiatives.

Reagents & Kits are anticipated to dominate the market in the forecast period. A combination of increasing demand for blood transfusions, technological advancements, rising awareness of blood safety, and government initiatives is driving the growth of the reagents and kits segment.

The automated segment is the fastest-growing segment in the market. A combination of increased efficiency, technological advancements, cost savings, and growing demand for blood testing is driving the growth of the automated blood testing method.

North America region is projected to account for the fastest growth rate in the forecast period. The growth of the blood testing market in North America is driven by a combination of factors, including the growing prevalence of chronic diseases, technological advancements, strong healthcare infrastructure, increasing focus on preventive healthcare, and favorable reimbursement policies.

Polaris Market Research has segmented the blood testing market by test, product, method, end-use, and region:

Blood Testing Market, Test Outlook (Revenue - USD Billion, 2020 - 2034)

CBC test

Blood glucose test

Lipid panel testing

Covid-19

BUN testing (Blood Urea Nitrogen)

A1C

Cortisol

Creatinine

Others

Blood Testing Market, Product Outlook (Revenue - USD Billion, 2020 - 2034)

Reagents & Kits

Instruments

Software

Blood Testing Market, Method Outlook (Revenue - USD Billion, 2020 - 2034)

Automated

Manual

Blood Testing Market, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)

Hospitals

Pathology labs

Blood banks

Diagnostic centres

Others

Blood Testing Market, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

118 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Patient Temperature Management Market Insights
4.1. Patient Temperature Management Market – Market Snapshot
4.2. Patient Temperature Management Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Chronic Diseases and Critical Illnesses Increasing ICU Admissions and Demand for Temperature Control Systems
4.2.1.2. Increasing Healthcare Spending Coupled with Well-Established Healthcare Infrastructure
4.2.2. Restraints and Challenges
4.2.2.1. High Equipment and Maintenance Costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Patient Temperature Management Market Trends
4.6. Value Chain Analysis
5. U.S. Patient Temperature Management Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Patient Temperature Management Market, by Product, 2020-2034 (USD Billion)
5.3. Patient Warning Systems
5.3.1. U.S. Patient Temperature Management Market, by Patient Warning Systems, by Region, 2020-2034 (USD Billion)
5.3.1.1. U.S. Patient Temperature Management Market, by Conventional Warning Systems, by Region, 2020-2034 (USD Billion)
5.3.1.2. U.S. Patient Temperature Management Market, by Surface Warning Systems, by Region, 2020-2034 (USD Billion)
5.3.1.3. U.S. Patient Temperature Management Market, by Intravascular Warning Systems, by Region, 2020-2034 (USD Billion)
5.4. Patient Cooling Systems
5.4.1. U.S. Patient Temperature Management Market, by Patient Cooling Systems, by Region, 2020-2034 (USD Billion)
5.4.1.1. U.S. Patient Temperature Management Market, by Conventional Warning Systems, by Region, 2020-2034 (USD Billion)
5.4.1.2. U.S. Patient Temperature Management Market, by Surface Warning Systems, by Region, 2020-2034 (USD Billion)
5.4.1.3. U.S. Patient Temperature Management Market, by Intravascular Warning Systems, by Region, 2020-2034 (USD Billion)
6. U.S. Patient Temperature Management Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Patient Temperature Management Market, by Application, 2020-2034 (USD Billion)
6.3. General Surgery
6.3.1. U.S. Patient Temperature Management Market, by General Surgery, by Region, 2020-2034 (USD Billion)
6.4. Cardiology
6.4.1. U.S. Patient Temperature Management Market, by Cardiology, by Region, 2020-2034 (USD Billion)
6.5. Pediatrics
6.5.1. U.S. Patient Temperature Management Market, by Pediatrics, by Region, 2020-2034 (USD Billion)
6.6. Neurology
6.6.1. U.S. Patient Temperature Management Market, by Neurology, by Region, 2020-2034 (USD Billion)
6.7. Orthopedic Surgery
6.7.1. U.S. Patient Temperature Management Market, by Orthopedic Surgery, by Region, 2020-2034 (USD Billion)
6.8. Thoracic Surgery
6.8.1. U.S. Patient Temperature Management Market, by Thoracic Surgery, by Region, 2020-2034 (USD Billion)
6.9. Other
6.9.1. U.S. Patient Temperature Management Market, by Other, by Region, 2020-2034 (USD Billion)
7. U.S. Patient Temperature Management Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Patient Temperature Management Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
7.3.1. U.S. Patient Temperature Management Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Ambulatory surgical centers
7.4.1. U.S. Patient Temperature Management Market, by Ambulatory surgical centers, by Region, 2020-2034 (USD Billion)
7.5. Neonatal care units
7.5.1. U.S. Patient Temperature Management Market, by Neonatal care units, by Region, 2020-2034 (USD Billion)
7.6. Specialized clinics
7.6.1. U.S. Patient Temperature Management Market, by Specialized clinics, by Region, 2020-2034 (USD Billion)
7.7. Other end-users
7.7.1. U.S. Patient Temperature Management Market, by Other end-users, by Region, 2020-2034 (USD Billion)
8. U.S. Patient Temperature Management Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Patient Temperature Management Market Assessment, By Country, 2020-2034 (USD Billion)
8.3. Patient Temperature Management Market – U.S.
8.3.1. U.S.: Patient Temperature Management Market, by Product, 2020-2034 (USD Billion)
8.3.2. U.S.: Patient Temperature Management Market, by Application, 2020-2034 (USD Billion)
8.3.3. U.S.: Patient Temperature Management Market, by End Use, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. 3M Company
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Atom Medical Corporation
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Augustine Surgical, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Bard Medical Division
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Cincinnati Sub-Zero Products, LLC
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Drägerwerk AG & Co. KGaA
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Geratherm Medical AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. ICU Medical, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Inditherm Plc
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Medtronic plc
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Smiths Medical
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. The Surgical Company Group
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.